Envonalkib

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Envonalkib is a pharmaceutical drug for cancer treatment. It belongs to the class of anaplastic lymphoma kinase inhibitors (ALK inhibitors). In China, it is approved for the treatment of patients with ALK-positive locally advanced or metastatic non-small cell lung cancer (NSCLC) who have not received treatment with ALK inhibitors.

Envonalkib is a pharmaceutical drug for cancer treatment. It belongs to the class of anaplastic lymphoma kinase inhibitors (ALK inhibitors). In China, it is approved for the treatment of patients with ALK-positive locally advanced or metastatic non-small cell lung cancer (NSCLC) who have not received treatment with ALK inhibitors.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1374092561 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

1 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.